MedPath

Optimal blood pressure control through improved adherence to antihypertensive medication after shared decision making in people with type 2 diabetes (T2DM)

Withdrawn
Conditions
type 2 diabetes
10012653
Registration Number
NL-OMON45993
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
264
Inclusion Criteria

1. Adults (>18 years) with T2DM AND
2. BP >140/90 mm Hg ( people * 80 years) or
> 160/90 mmHg (people > 80 years, based on Dutch guidelines), measured during the last-check up at the general practice/ endocrinologist using a 30-minute bloodpressure monitor. AND
3. use of three adequately dosed antihypertensive medications, including a diuretic during at least the past 3 months

Exclusion Criteria

1. type 1 diabetes;
2. eGFR < 30 ml/min;
3. a history of alcoholism or drug abuse;
4. dementia or major psychiatric disorder that is likely to invalidate informed consent (IC), or limit the ability of the individual to comply with the protocol requirements.
5. Unwillingness to provide a written informed consent.
6. Pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath